A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | |
Huang, Anfei; Peng, Di; Guo, Huanhuan; Ben, Yinyin; Zuo, Xiangyang; Wu, Fei; Yang, Xiaoli; Teng, Fei; Li, Zhen; Qian, Xueming | |
2017 | |
卷号 | 7页码:42687 |
ISSN号 | 2045-2322 |
DOI | 10.1038/srep42687 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367294 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Huang, Anfei,Peng, Di,Guo, Huanhuan,et al. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies[J],2017,7:42687. |
APA | Huang, Anfei.,Peng, Di.,Guo, Huanhuan.,Ben, Yinyin.,Zuo, Xiangyang.,...&Qin, F. Xiao-Feng.(2017).A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies.,7,42687. |
MLA | Huang, Anfei,et al."A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies".7(2017):42687. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论